Ko-Med Centra Kliniczne Sp. z o.o.
- Address
- lock Available on a paid plan
Virus Diseases and Bacterial Infections and Mycoses
At Ko-Med Centra Kliniczne Sp. z o.o. in Staszow, clinical research in General Medicine focuses on common infectious threats in older adults, especially influenza, RSV-associated disease, and prevention of invasive disease caused by Escherichia coli. These studies are designed to assess how well new and existing vaccines protect against infection and support stronger immune responses.
- Evaluating vaccine effectiveness for influenza in adults 65 and older
- Studying protection against invasive extraintestinal pathogenic Escherichia coli disease
- Assessing immune response and protection against RSV in older adults
The site’s trials mainly compare vaccine performance, safety, and immune response to help improve prevention of respiratory and bacterial infections in aging populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 38 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ko-Med Centra Kliniczne Sp. z o.o.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase III, open-label, randomized, controlled, multi-country study to evaluate the immune response, safety and reactogenicity of RSVPreF3 OA investigational vaccine when co-administered with 20-valent pneumococcal conjugate vaccine (PCV20) in adults aged 60 years and older. | GlaxoSmithKline Biologicals | Phase III | Not Recruiting | Aug 2023 | May 2024 |
IMP list
lock Showing 1 of 38 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type) | 2 | Unknown | 2023-10-20 | 2023-11-06 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.